S100A9 and neoplasm: It will be critical to find more clinically relevant models, to further investigate the role of S100A9 signaling in anti-tumor immunity and determine how we can best target this pathway to increase accumulation of beneficial immune cells in tumor, while reducing detrimental effects that support tumor progression and therapy resistance.